BOOKS BY CATEGORY
Your Account
Oncogene-Directed Therapies
Price
Quantity
€146.39
(To see other currencies, click on price)
Paperback / softback
Add to basket  

MORE ABOUT THIS BOOK

Main description:

Prominent investigators and clinicians summarize in a balanced blend of fundamental science, basic research, experimental therapeutics, and early clinical experiences, what is known about oncogenes and oncogenesis, and describe how that knowledge can be used to treat the cancer. The contributors explain how, why, and under what conditions certain proteins acquire the ability to transform eukaryotic cells, and detail the crucial biological consequences of this oncogenic transformation, particularly for cellular mitogenesis, survival, differentiation, migration, proteolysis, or angiogenic competence. Their articles thoroughly explicate the premises, principles, techniques, and approaches to oncogene targeting in various types of human cancer by using signal transduction inhibitors, immunological targeting methods, and antisense gene therapy.


Contents:

Part I. Basic Concepts in Oncogene Research

Genetic Basis of Cancer Progression
Susan J. Done and Jeremy A. Squire

The Molecular Basis of Chromosomal Instability in Human Cancer Cells
Daniel P. Cahill

Signal Transduction Networks: Ras as a Paradigm
Frank McCormick

Oncogenic Receptor Tyrosine Kinases
Mark H. Kirschbaum, Mina D. Marmor, and Yosef Yarden

Ras-Mediated Deregulation of Gene Expression and Contribution to Oncogenesis
Gretchen A. Murphy and Channing J. Der

The Interplay Between Tumor Suppressor Genes and Oncogenes in Tumorigenesis
Eric C. Holland

Genetic Basis of Altered Responsiveness of Cancer Cells to Their Microenvironment
Amato J. Giaccia

Part II. The Functional Impact of Oncogene Expression on Cancer Cells-Therapeutic Implications

Deregulation of Cell Cycle Progression by Oncogenic Transformation
Marcelo L. Rodriguez-Puebla, Adrian M. Senderowicz, and Claudio J. Conti

Oncogenes as Regulators of Cell Survival: The Role of Oncogenes and Tumor Suppressor Genes in the Induction of Resistance to Anoikis and Hypoxia
Kirill Rosen and Jorge Filmus

Oncogenes and Tumor Angiogenesis
Janusz Rak and Robert S. Kerbel

Oncogenes as Therapeutic Targets to Prevent Metastasis
Ann F. Chambers and Hemanth J. Varghese

The Impact of Oncogenes on Tumor Maintenance
Senji Shirasawa and Takehiko Sasazuki

Primary and Secondary Events in Oncogene-Driven Tumor Development: Lessons from Transgenic Model Systems
Michaela Herzig and Gerhard Christofori

Part III. Oncogenes as Targets for Anticancer Therapy In Vivo

Targeting Oncogenes in Hematopoietic Malignancies
Michael E. O'Dwyer and Brian J. Druker

Clinical Evaluation of Agents Targeting Epidermal Growth Factor Receptor (EGFR) in Cancer
Edward H. Lin and James L. Abbruzzese

Inhibition of the HER-2/neu Oncogene: A Translational Research Model for the Development of Future Targeted Therapies
Gottfried E. Konecny, Jane Arboleda, Dennis J. Slamon, and Mark Pegram

Farnesyltransferase Inhibitors as Anticancer Agents
Adrienne D. Cox

Targeting Oncogenic Signaling Pathways in Human Astrocytomas
Gelareh Zadeh and Abhijit Guha

Targeting Oncogenes in Pediatric Malignancies
Giannoula Klement and Robert S. Kerbel

Inhibiting Signal Transduction as an Approach to Radiosensitizing Tumor Cells
Eric J. Bernhard, Anjali K. Gupta, Elizabeth Cohen-Jonathan, Ruth J. Muschel, Stephen M. Hahn, and W. Gillies McKenna

Oncogenes as Targets for Cancer Vaccines
Samir N. Khleif and Joseph A. Lucci, III

Bcl-2 Antisense Oligonucleotides Therapy for Cancer: Targeting the Mitochondria
Finbarr E. Cotter and Dean A. Fennell

Index


PRODUCT DETAILS

ISBN-13: 9781468497380
Publisher: Springer (Humana Press Inc.)
Publication date: July, 2012
Pages: 487
Weight: 950g
Availability: Available
Subcategories: Oncology
Related books
From the same series

CUSTOMER REVIEWS

Average Rating